Vanguard Group Portfolio holdings
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$4.14B |
| 2 |
Microsoft
MSFT
|
+$2.98B |
| 3 |
UnitedHealth
UNH
|
+$2.85B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$2.59B |
| 5 |
CRH
CRH
|
+$2.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$2.01B |
| 2 |
Flutter Entertainment
FLUT
|
+$1.59B |
| 3 |
Welltower
WELL
|
+$841M |
| 4 |
SMAR
Smartsheet Inc.
SMAR
|
+$798M |
| 5 |
ALTR
Altair Engineering Inc
ALTR
|
+$752M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.01% |
| 2 | Financials | 14.44% |
| 3 | Healthcare | 11% |
| 4 | Consumer Discretionary | 10.05% |
| 5 | Industrials | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
Sensus Healthcare
SRTS
$47.9M
| $3.5M | ﹤0.01% |
740,022
| – | – |
|
3302
UNIFI
UFI
$119M
| $3.49M | ﹤0.01% |
725,794
| – | – |
|
3303
CervoMed
CRVO
$23.9M
| $3.46M | ﹤0.01% |
378,662
-4,825
| -1% | -$18.4K |
|
3304
FreightCar America
RAIL
$261M
| $3.45M | ﹤0.01% |
623,469
+14,574
| +2% | +$138K |
|
3305
Genelux
GNLX
$132M
| $3.45M | ﹤0.01% |
1,276,951
+90,133
| +8% | +$338K |
|
3306
XBiotech
XBIT
$68M
| $3.44M | ﹤0.01% |
1,062,772
-1,832
| -0.2% | -$6.32K |
|
3307
Birkenstock
BIRK
$7.12B
| $3.43M | ﹤0.01% |
74,796
+2,453
| +3% | +$129K |
|
3308
Crawford & Co Class A
CRD.A
$532M
| $3.42M | ﹤0.01% |
299,550
-1,234
| -0.4% | -$14.4K |
|
3309
Zevia
ZVIA
$122M
| $3.4M | ﹤0.01% |
1,576,029
+214,739
| +16% | +$703K |
|
3310
Pagaya Technologies
PGY
$1.61B
| $3.4M | ﹤0.01% |
324,279
+26,268
| +9% | +$291K |
|
3311
Strawberry Fields REIT
STRW
$191M
| $3.38M | ﹤0.01% |
284,086
+100,074
| +54% | +$1.16M |
|
3312
Vanguard Information Technology ETF
VGT
$139B
| $3.35M | ﹤0.01% |
49,440
+1,040
| +2% | +$78.4K |
|
3313
Innovative Solutions & Support
ISSC
$327M
| $3.34M | ﹤0.01% |
531,133
+17,944
| +3% | +$155K |
|
3314
HireQuest
HQI
$180M
| $3.34M | ﹤0.01% |
280,409
-3,759
| -1% | -$50.8K |
|
3315
Establishment Labs
ESTA
$2.72B
| $3.32M | ﹤0.01% |
81,289
+2,466
| +3% | +$91.9K |
|
3316
GrowGeneration
GRWG
$86.5M
| $3.31M | ﹤0.01% |
3,067,002
-11,874
| -0.4% | -$15.9K |
|
3317
Inovio Pharmaceuticals
INO
$55.7M
| $3.31M | ﹤0.01% |
2,028,960
+355,372
| +21% | +$713K |
|
3318
CF Bankshares
CFBK
$234M
| $3.31M | ﹤0.01% |
150,031
+19,160
| +15% | +$448K |
|
3319
Alpha Pro Tech
APT
$50.4M
| $3.3M | ﹤0.01% |
659,531
| – | – |
|
3320
iShares Core MSCI EAFE ETF
IEFA
$190B
| $3.28M | ﹤0.01% |
43,377
+8,265
| +24% | +$618K |
|
3321
Dimensional US Core Equity 2 ETF
DFAC
$47.9B
| $3.28M | ﹤0.01% |
99,325
-2,739
| -3% | -$95.1K |
|
3322
Lifetime Brands
LCUT
$191M
| $3.27M | ﹤0.01% |
662,701
-1,861
| -0.3% | -$10.1K |
|
3323
Children's Place
PLCE
$54.3M
| $3.26M | ﹤0.01% |
372,858
-322
| -0.1% | -$3K |
|
3324
CytomX Therapeutics
CTMX
$675M
| $3.25M | ﹤0.01% |
5,117,376
-44,926
| -0.9% | -$34.8K |
|
3325
TScan Therapeutics
TCRX
$48.6M
| $3.25M | ﹤0.01% |
2,356,746
-25,787
| -1% | -$55.8K |
|
Similar funds
Vanguard Group's Q1 2025 Portfolio in Review
As of Q1 2025, Vanguard Group held 4,371 positions worth $5.53T, down 3.7% from $5.74T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.9%. Vanguard Group opened 78 new positions and exited 91, leaving the 4,371-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 31% a quarter earlier, followed by Financials and Healthcare.
- Vanguard Group's largest Q1 2025 buy was Sandisk: 13,684,572 shares worth $652M.
- Vanguard Group added most to Eli Lilly in Q1 2025, an estimated $4.14B increase.
- Vanguard Group's biggest Q1 2025 reduction was Palantir, cutting an estimated $2.01B.
- Vanguard Group fully exited Smartsheet Inc. in Q1 2025, selling an estimated $798M.
- Vanguard Group's ten largest holdings make up 26% of its $5.53T portfolio in Q1 2025.
- Vanguard Group opened 78 new positions and closed 91 in Q1 2025.
- Vanguard Group's portfolio value fell 3.7% quarter-over-quarter to $5.53T.
Based on Vanguard Group's 13F filing for Q1 2025, filed 9 May 2025.